norethindrone and Diabetes Mellitus, Type 2

norethindrone has been researched along with Diabetes Mellitus, Type 2 in 14 studies

Research

Studies (14)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (7.14)	18.7374
1990's	0 (0.00)	18.2507
2000's	12 (85.71)	29.6817
2010's	1 (7.14)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adamson, KA; Chisholm, J; Kilbride, L; Mackay, L	1
Dhindsa, P; Forsyth, J; Mansell, P; Scott, AR	1
Crawford, L; Gallacher, S; Greer, IA; Jaap, AJ; Kelly, A; Lowe, GD; McKenzie, J; Paterson, K; Petrie, JR; Rumley, A; Sattar, N	1
Andersson, B; Glassell, M; Mattsson, LA; Thunell, L	1
Cleland, SJ; Hillier, C; Kernohan, AF; Lumsden, MA; McConnell, J; Petrie, JR; Sattar, N; Small, M; Spiers, A	1
Fisher, BM; Jaap, AJ; McKenzie, J; Paterson, K; Sattar, N; Stanley, A	1
Cleland, SJ; Connell, JM; Hilditch, T; Kernohan, AF; Lumsden, MA; Petrie, JR; Sattar, N; Small, M	1
Collins, PB; Johnson, A; Owens, D; Tomkin, GH	1
Bajart, L; Berthezène, F; Boissel, JP; Bully, C; Cornu, C; Cousin, P; Darsy, P; Ffrench, P; Mercier, C; Orgiazzi, J; Pommet-Nicot, C; Pugeat, M; Riou, JP	1
Puolakka, J; Saltevo, J; Ylikorkala, O	1
Connell, JM; Hillier, C; Lowe, GD; Lumsden, MA; Perera, M; Petrie, JR; Sattar, N; Small, M	1
Darko, DA; Dornhorst, A; Kennedy, G; Mandeno, RC; Seed, M	1
Connell, JM; Hillier, C; Lumsden, MA; Perera, M; Petrie, JR; Sattar, N; Small, M	1
Berger, W; Chabot, V; Stamm, H	1

Reviews

1 review(s) available for norethindrone and Diabetes Mellitus, Type 2

Article	Year
Hormone replacement therapy for women with type 1 diabetes mellitus. The Cochrane database of systematic reviews, 2013, Jun-06, Issue:6 Topics: Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Estradiol; Estrogen Replacement Therapy; Female; Humans; Norethindrone; Norethindrone Acetate; Postmenopause; Randomized Controlled Trials as Topic; Risk Factors	2013

Trials

11 trial(s) available for norethindrone and Diabetes Mellitus, Type 2

Article	Year
Effect of hormone replacement therapy on cardiovascular risk factors in postmenopausal women with diabetes. Diabetes, obesity & metabolism, 2004, Volume: 6, Issue:1 Topics: Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipids; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Risk Factors	2004
Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk? Clinical endocrinology, 2003, Volume: 59, Issue:6 Topics: Autoantigens; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Humans; Interleukin-6; Linear Models; Menopause; Middle Aged; Norethindrone; Risk Factors; Tissue Plasminogen Activator; Triglycerides	2003
The effect of continuous combined HRT on glucose homeostasis and plasma lipids. A placebo-controlled study in postmenopausal women with type 2 diabetes. Maturitas, 2006, Mar-20, Volume: 53, Issue:4 Topics: Aged; Blood Glucose; Body Mass Index; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hyperandrogenism; Lipid Metabolism; Middle Aged; Norethindrone; Norethindrone Acetate; Sex Hormone-Binding Globulin; Statistics, Nonparametric	2006
Effects of low-dose continuous combined HRT on vascular function in women with type 2 diabetes. Diabetes & vascular disease research, 2004, Volume: 1, Issue:2 Topics: Arteries; Biopsy; Blood Flow Velocity; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Endothelium, Vascular; Estradiol; Estrogen Replacement Therapy; Female; Humans; Intercellular Adhesion Molecule-1; Middle Aged; Norethindrone; Vascular Cell Adhesion Molecule-1; Vascular Resistance; Vasoconstriction; Vasodilation	2004
Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial. Clinical endocrinology, 2006, Volume: 65, Issue:1 Topics: Aged; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Case-Control Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; gamma-Glutamyltransferase; Humans; Linear Models; Liver; Liver Function Tests; Menopause; Middle Aged; Norethindrone	2006
Effects of low-dose continuous combined hormone replacement therapy on glucose homeostasis and markers of cardiovascular risk in women with type 2 diabetes. Clinical endocrinology, 2007, Volume: 66, Issue:1 Topics: Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Female; Homeostasis; Humans; Hypoglycemic Agents; Insulin; Middle Aged; Norethindrone; Postmenopause; Risk Factors; Statistics, Nonparametric; Triglycerides	2007
Lipoproteins and low-dose estradiol replacement therapy in post-menopausal Type 2 diabetic patients: the effect of addition of norethisterone acetate. Diabetic medicine : a journal of the British Diabetic Association, 2000, Volume: 17, Issue:4 Topics: Aged; Carrier Proteins; Cholesterol; Cholesterol Ester Transfer Proteins; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Glycoproteins; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Triglycerides	2000
Postmenopause hormone treatment in women with NIDDM or impaired glucose tolerance: the MEDIA randomized clinical trial. Maturitas, 2000, Dec-29, Volume: 37, Issue:2 Topics: Biomarkers; Chlormadinone Acetate; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Estrogens; Female; Glucose Intolerance; Hormone Replacement Therapy; Humans; Informed Consent; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause	2000
Plasma endothelin in postmenopausal women with type 2 diabetes mellitus and metabolic syndrome: a comparison of oral combined and transdermal oestrogen-only replacement therapy. Diabetes, obesity & metabolism, 2000, Volume: 2, Issue:5 Topics: Administration, Cutaneous; Administration, Oral; Biomarkers; Body Constitution; Body Mass Index; Cholesterol, HDL; Cross-Over Studies; Diabetes Mellitus, Type 2; Endothelin-1; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hyperlipidemias; Hypertension; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Reference Values; Syndrome; Triglycerides	2000
The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study. The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:3 Topics: Administration, Cutaneous; Blood Coagulation Factors; Cholesterol; Cholesterol, HDL; Coronary Disease; Diabetes Mellitus, Type 2; Endothelium, Vascular; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Humans; Lipoproteins; Middle Aged; Norethindrone; Placebos; Postmenopause; Triglycerides; von Willebrand Factor	2001
Glycaemic control and plasma lipoproteins in menopausal women with Type 2 diabetes treated with oral and transdermal combined hormone replacement therapy. Diabetes research and clinical practice, 2001, Volume: 54, Issue:3 Topics: Administration, Cutaneous; Administration, Oral; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; E-Selectin; Estradiol; Female; Glycated Hemoglobin; Hormone Replacement Therapy; Humans; Insulin; Norethindrone; Postmenopause; Progesterone Congeners; Prospective Studies; Triglycerides	2001

Other Studies

2 other study(ies) available for norethindrone and Diabetes Mellitus, Type 2

Article	Year
Hormone replacement therapy can augment vascular relaxation in post-menopausal women with type 2 diabetes. Human reproduction (Oxford, England), 2002, Volume: 17, Issue:2 Topics: Acetylcholine; Blood Vessels; Bradykinin; Buttocks; Diabetes Mellitus, Type 2; Endothelium, Vascular; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Nitroprusside; Norethindrone; Postmenopause; Progesterone Congeners; Vasodilation; Vasodilator Agents	2002
[Guidelines of the Swiss Diabetic Association on diabetes and contraception]. Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1986, May-20, Volume: 75, Issue:21 Topics: Blood Glucose; Contraceptives, Oral, Hormonal; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Estrogens; Female; Humans; Norethindrone; Norgestrel; Obesity; Pregnancy; Pregnancy in Diabetics; Societies, Medical; Switzerland	1986

Article

Year

Hormone replacement therapy can augment vascular relaxation in post-menopausal women with type 2 diabetes.

Human reproduction (Oxford, England), 2002, Volume: 17, Issue:2

Topics: Acetylcholine; Blood Vessels; Bradykinin; Buttocks; Diabetes Mellitus, Type 2; Endothelium, Vascular; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Nitroprusside; Norethindrone; Postmenopause; Progesterone Congeners; Vasodilation; Vasodilator Agents

2002

[Guidelines of the Swiss Diabetic Association on diabetes and contraception].

Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1986, May-20, Volume: 75, Issue:21

Topics: Blood Glucose; Contraceptives, Oral, Hormonal; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Estrogens; Female; Humans; Norethindrone; Norgestrel; Obesity; Pregnancy; Pregnancy in Diabetics; Societies, Medical; Switzerland

1986